ENST00000502301.6:n.218-18246T>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000502301.6(MIR9-2HG):n.218-18246T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0443 in 152,292 control chromosomes in the GnomAD database, including 491 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.044 ( 491 hom., cov: 31)
Consequence
MIR9-2HG
ENST00000502301.6 intron
ENST00000502301.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.39
Publications
2 publications found
Genes affected
MIR9-2HG (HGNC:42810): (MIR9-2 host gene) This is an evolutionarily conserved gene that produces alternatively spliced long non-coding RNAs that may be expressed predominantly in the brain and visual cortex. These transcripts may be involved in tumorigenesis, as depletion by siRNA suppressed glioma cell division. Transcripts may also bind to and regulate the activity of miR-411-5p and argonaut 2, thereby altering the expression of genes involved in tumor growth. [provided by RefSeq, Nov 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.355 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MIR9-2HG | ENST00000502301.6 | n.218-18246T>A | intron_variant | Intron 3 of 4 | 4 | |||||
| MIR9-2HG | ENST00000504034.3 | n.166-18246T>A | intron_variant | Intron 1 of 7 | 3 | |||||
| MIR9-2HG | ENST00000506014.6 | n.152-18246T>A | intron_variant | Intron 2 of 3 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0442 AC: 6722AN: 152174Hom.: 486 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
6722
AN:
152174
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0443 AC: 6740AN: 152292Hom.: 491 Cov.: 31 AF XY: 0.0483 AC XY: 3598AN XY: 74456 show subpopulations
GnomAD4 genome
AF:
AC:
6740
AN:
152292
Hom.:
Cov.:
31
AF XY:
AC XY:
3598
AN XY:
74456
show subpopulations
African (AFR)
AF:
AC:
1831
AN:
41576
American (AMR)
AF:
AC:
731
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
16
AN:
3468
East Asian (EAS)
AF:
AC:
1909
AN:
5178
South Asian (SAS)
AF:
AC:
644
AN:
4818
European-Finnish (FIN)
AF:
AC:
332
AN:
10622
Middle Eastern (MID)
AF:
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1141
AN:
68020
Other (OTH)
AF:
AC:
108
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
290
579
869
1158
1448
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
804
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.